Mangalam Drugs And Organics Limited (MANGALAM)
ISIN: INE584F01014 Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
143.8
2.25(1.59%)

Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications. The company was incorporated in 1972 and is based in Mumbai, India.

Pricing Updates

TODAY'S HIGH

144.9

TODAY'S LOW

140.5

52 WEEK HIGH

196.95

52 WEEK LOW

95.5

Major Holders

% of Shares Held by
All Insider

51.45%

% of Shares Held by
Institutions

0.00%

% of Float Held by
Institutions

0.00%

Number of Institutions
Holding Shares

0

Company Overview

MARKET CAP

227.60 Cr.

ETERPRISE VALUE

307.89 Cr.

NO. OF SHARES

1.58 Cr.

BOOK VALUE

95.177

DIV. YIELD

0.5%

DEBT

87.90 Cr.

GROSS PROFIT

140.92 Cr.

CASH

1.95 Cr.

REVENUE

447.56 Cr.

REVENUE/SHARE

282.778

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments20.71 Lakhs20.71 Lakhs1.66 Lakhs1.66 Lakhs
Change To Liabilities11.15 Cr.-13.91 Cr.24.17 Cr.-5.21 Cr.
Total cashflows from Investing Activities-27.32 Cr.-31.28 Cr.-6.87 Cr.-9.25 Cr.
Net Borrowings9.15 Cr.12.02 Cr.-13.07 Cr.-2.79 Cr.
Total Cash from Financing Activities-2.01 Cr.2.69 Cr.-23.47 Cr.-11.43 Cr.
Other Liabilities28.94 Cr.1.32 Cr.-4.79 Cr.2.16 Cr.
Total Assets0000
Net Income19.65 Cr.27.97 Cr.8.25 Cr.-8.03 Cr.
Change in Cash1.36 Cr.-1.03 Cr.19.58 Lakhs1 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities30.69 Cr.27.54 Cr.30.54 Cr.21.69 Cr.
Depreciation10.24 Cr.8.63 Cr.8.21 Cr.7.51 Cr.
Other Cashflows from Investing Activities5 k5 k4 k2.01 Lakhs
Dividends Paid0000
Change to Inventory-58.51 Cr.6.25 Cr.8.61 Cr.-13.31 Cr.
Change to Account Receivables7.82 Cr.-13.60 Cr.-22.35 Cr.27.57 Cr.
Other Cashflows from Financing Activities-11.16 Cr.-9.32 Cr.-10.40 Cr.-8.64 Cr.
Change to Net Income11.39 Cr.10.34 Cr.8.43 Cr.10.99 Cr.
Capital Expenditures-27.66 Cr.-31.43 Cr.-6.93 Cr.-9.33 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax27.73 Cr.39.51 Cr.6.25 Cr.-5.73 Cr.
Minority InterestNoneNoneNoneNone
Net Income35.29 Cr.44.55 Cr.15.80 Cr.2.79 Cr.
Selling General Administrative37.25 Cr.30.49 Cr.27 Cr.26.57 Cr.
Gross Profit140.92 Cr.124.51 Cr.84.66 Cr.71.45 Cr.
Ebit35.29 Cr.44.55 Cr.15.80 Cr.2.79 Cr.
Operating Income35.29 Cr.44.55 Cr.15.80 Cr.2.79 Cr.
Other Operating Expenses58.12 Cr.40.29 Cr.33.62 Cr.34.99 Cr.
Interest Expense-11.16 Cr.-6.32 Cr.-6.49 Cr.-6.61 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense8.07 Cr.11.54 Cr.-2 Cr.2.29 Cr.
Total Revenue447.56 Cr.380.14 Cr.282.35 Cr.227.57 Cr.
Total Operating Expenses412.26 Cr.335.58 Cr.266.54 Cr.224.78 Cr.
Cost of Revenue306.63 Cr.255.62 Cr.197.69 Cr.156.12 Cr.
Total Other Income Expense Net-7.56 Cr.-5.03 Cr.-9.55 Cr.-8.53 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.19.65 Cr.27.97 Cr.8.25 Cr.-8.03 Cr.
Net Income Applicable to Common Shares19.65 Cr.27.97 Cr.8.25 Cr.-8.03 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets13.87 Cr.8.47 Cr.6.13 Cr.3.76 Cr.
Capital Surplus022.37 Cr.22.37 Cr.22.37 Cr.
Total Liabilities177.86 Cr.131.88 Cr.126.72 Cr.115.69 Cr.
Stock Holder Equity150.56 Cr.130.96 Cr.103.93 Cr.95.66 Cr.
Minority Interest0000
Other Liabilities14.70 Cr.1.75 Cr.1.88 Cr.28.78 Lakhs
Total Assets328.42 Cr.262.84 Cr.230.66 Cr.211.35 Cr.
Common Stock15.82 Cr.15.82 Cr.15.82 Cr.15.82 Cr.
Retained Earnings093.30 Cr.65.33 Cr.57.07 Cr.
Other Liabilities17.43 Cr.14.17 Cr.12.28 Cr.14.33 Cr.
Good Will0000
Treasury Stock134.73 Cr.-54.44 Lakhs40.34 Lakhs38.01 Lakhs
Other Assets5.28 Cr.6.30 Cr.8.95 Cr.2.38 Cr.
Cash1.95 Cr.59.18 Lakhs1.62 Cr.1.43 Cr.
Current Liabilities135.10 Cr.107.64 Cr.109.46 Cr.90.81 Cr.
Long Term Asset Charges0000
Short Long Term Debt11.60 Cr.5.90 Cr.4 Cr.3.78 Cr.
Other Stockholder Equity134.73 Cr.-54.44 Lakhs40.34 Lakhs38.01 Lakhs
Property Plant Equipment126.79 Cr.115.87 Cr.96.17 Cr.99.92 Cr.
Total Cur. Assets182.46 Cr.131.97 Cr.119.17 Cr.105.03 Cr.
Long Term Investments43 k22.35 Lakhs22.35 Lakhs24.01 Lakhs
Net Tangible Assets136.68 Cr.122.48 Cr.97.80 Cr.91.89 Cr.
Short Term Investments0000
Net Receivables46.52 Cr.53.60 Cr.39.99 Cr.17.63 Cr.
Long Term Debt20.11 Cr.6.87 Cr.4.17 Cr.8.59 Cr.
Inventory117.10 Cr.58.58 Cr.64.84 Cr.73.45 Cr.
Accounts Payable54.54 Cr.42.67 Cr.56.59 Cr.32.41 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account